Общество с ограниченной ответственностью "ХИЛИНГ ФАРМ" (RU)
发明人:
Баранников Александр Евгеньевич (RU),Новаковский Владимир Владимирович (RU)
申请号：
RU2013133938/15
公开号：
RU2013133938A
申请日:
2013.07.22
申请国别(地区):
RU
年份:
2015
代理人:
摘要：
1. Therapeutic composition, characterized in that it comprises 1-20% by weight of regenerant methyluracil, 0.05-2% by weight of a calcium channel blocker -.. Calcium antagonist, 0.05-2 wt% nitric oxide donor, 0.1. . 4 wt% of a local anesthetic, pharmacologically acceptable carrier - ostalnoe.2. Pharmacological composition according to claim. 1, characterized in that the calcium channel blocker used amlodipine, anipamil, aranidipine, azelnidipine, barnidipine, benidipine, bepridil, darodipin, dildiazem, cilnidipine, clevidipine, isradipine, efonidipine, felodipine, lasidipin, lidofazin, lercanidipine , manidipine, mepirodipin, nicardipine, nifedipine, niludipin, nilvadipine, nimodipine, nisoldipine, nitrendipine, perhexiline, types, verapamil, pranidipine, their salts, solvates, hydrates, and mixtures of any of nih.3. Pharmacological composition according to claim. 1, characterized in that the nitric oxide donor used isopropyl nitrate, glyceryl-1-mononitrate, glyceryl-1,2-dinitrate, glyceryl 1,2-dinitrate, glyceryl trinitrate, 1,2-butane, 4-triol-trinitrate, erythritol tetranitrate, pentaerythrityl tetranitrate, isosorbide mononitrate, isosorbide 2-mononitrate, isosorbide-5-mononitrate, isosorbide dinitrate or a mixture of these soedineniy.4. Pharmacological composition according to claim. 1, characterized in that the local anesthetic used proxymetacaine, bupivacaine, benzocaine, bromaniliddietilaminopropanovaya acid, articaine, oxybuprocaine, lidocaine, tetracaine, dyclonine, dimethylaminoethyl ester n-butilaminobenzoynoy acid, mepivacaine, ropivacaine, procaine, trimekain or soedineniy.5 mixture of these. Therapeutic composition, characterized in that it consists of 5 wt.% Met1. Фармакологическая композиция, отличающаяся тем, что содержит 1-20 мас.% регенеранта метилурацила, 0,05-2 мас.% блокатора кальциевых каналов - антагонист кальция, 0,05-2 мас.% донора оксида азота, 0,1-4 мас.% местного анестетика, фармакологически приемлемый носитель - остальное.2. Фармаколог
